运动瘤学成长了
Kathryn H Schmitz1, Joachim Wiskemann2, Anne M May3,4
1Division of Hematology Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Journal of the National Cancer Institute. Monographs
|August 19, 2025
概括
运动瘤学是一个不断发展的领域,有广泛的研究和指导方针. 一个新的国际运动瘤学会旨在将运动作为所有患者的标准癌症护理.
科学领域:
- 运动瘤学运动瘤学
- 癌症康复康复 癌症康复
- 临床瘤学临床瘤学
背景情况:
- 运动瘤学有着坚实的科学基础,有超过3万篇同行评审的出版物.
- 主要医疗机构已发布了癌症护理运动指南,得到随机对照试验的支持.
- 通过一个专门的国际组织,人们非常热衷于推动这个领域的发展.
研究的目的:
- 记录运动瘤学研究和实践的进展.
- 为建立国际运动瘤学会 (ISOX) 奠定基础.
- 促进运动作为瘤治疗标准的整合.
主要方法:
- 关于运动瘤学的科学文献综述.
- 分析主要医疗机构发布的指导方针.
- 记录该领域的历史发展和当前状况.
主要成果:
- 运动瘤学领域已经建立,有大量证据.
- 一个新的国际社会的形成即将到来.
- 专著提供了对该领域进展的全面概述.
结论:
- 运动瘤学是一个快速发展的学科.
- 国际运动瘤学会将成为研究人员和临床医生的中心枢纽.
- 最终的目标是确保所有癌症患者从运动中受益,作为标准护理.
相关概念视频
Exercise and Muscle Performance
1.6K
Exercise induces a range of adaptations in muscle tissue, depending on the type and duration of activity. Such physical training can be broadly categorized into two types: endurance exercises and resistance exercises.
Endurance exercises
Endurance exercises involve running, swimming, or cycling, which require repetitive movements with low force output. When a person engages in endurance exercise, a few noticeable changes occur in their skeletal muscles. For instance, the number of capillaries...
Endurance exercises
Endurance exercises involve running, swimming, or cycling, which require repetitive movements with low force output. When a person engages in endurance exercise, a few noticeable changes occur in their skeletal muscles. For instance, the number of capillaries...
1.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660


